ISL
NVAX icon

Ingalls & Snyder LLC’s Novavax NVAX Stock Holding History

Ingalls & Snyder LLC’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,500
Closed -$438K – 449
2022
Q2 		$438K Buy
7,500
+4,000
+114% +$207K 0.02% 296
2022
Q1 		$1.12M Sell
3,500
-800
-19% -$71.3K 0.05% 210
2021
Q4 		$1.38M Buy
4,300
+200
+5% +$34.4K 0.06% 189
2021
Q3 		$1.31M Buy
4,100
+100
+3% +$22K 0.06% 204
2021
Q2 		$1.28M Buy
+4,000
New +$733K 0.06% 217

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return